$95.00
SLU-PP-332 is a laboratory-developed compound that acts as a pan-agonist of the estrogen-related receptors ERRα, ERRβ, and ERRγ. It has been investigated for its ability to stimulate gene pathways linked to aerobic exercise and energy metabolism. Researchers are examining how this compound may influence mitochondrial function, endurance performance, and aspects of cardiometabolic health.
SLU-PP-332 has drawn interest in experimental research for its ability to activate estrogen-related receptors ERRα, ERRβ, and ERRγ, which are involved in regulating cellular energy metabolism. By stimulating these receptors, the compound may influence gene pathways associated with aerobic exercise and mitochondrial function. In preclinical studies, particularly in murine models, researchers have explored its potential effects on endurance capacity, metabolic efficiency, and overall cardiometabolic performance. Its interaction with pathways tied to energy utilization has made it a subject of investigation in studies related to exercise physiology and metabolic regulation.
These ranges are general, research-use suggestions to help you prepare your peptides. This calculator and recommended doses are not medical advice. Start low, assess tolerance, and adjust cautiously.
Discover more with Dynamic Pharmaceuticals’ SARMs collection. Explore a carefully selected range of compounds studied for their potential effects on muscle development and body composition. With detailed product information and convenient online ordering, it’s easy to compare your options and find the right fit for your research goals.
Activates the estrogen-related receptors ERRα, ERRβ and ERRγ, which regulate cellular energy metabolism.
Researched for its exercise-mimetic effects on endurance and fat oxidation in preclinical studies.
Dynamic Pharmaceuticals is committed to having the best customer support team that can help guide you on the best performance boosting supplements you need. We take pride in our reputation, and are constantly striving to bring you the best products there are for the Canadian market.
Dynamic Pharmaceuticals SLU-PP-332 contains 50 tablets of 500mcg SLU-PP-332 (per tablet).
As an investigational compound, the safety profile of SLU-PP-332 is still being studied. Because it directly targets nuclear receptors involved in metabolic regulation, it may influence multiple biological pathways throughout the body. Potential concerns in research settings could include alterations in metabolic signaling, hormone-related pathways, or cardiovascular responses depending on dosage and exposure duration. As with many experimental receptor agonists, careful monitoring is important during studies to evaluate possible unintended physiological effects.
SLU-PP-332 is primarily used in controlled laboratory and preclinical research environments, and standardized human dosing guidelines have not been established. In animal studies, dosing is carefully calculated to evaluate its effects on metabolic and endurance-related pathways while minimizing potential adverse responses. Researchers emphasize controlled administration, precise measurement, and monitoring when studying the compound due to its activity on key metabolic receptors. Any experimental use should follow established laboratory protocols and safety practices.
There are no reviews yet.